Ahmed K,Shoaib MH,Yousuf RI,Siddiqui F,Qazi F,Iftikhar J,Ahmed FR,Nasiri MI .1867 .Comparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LCESI-MS/MS method. Sci. Rep, 10(1) : .
Akhgari A,Abbaspour MR,Pirmoradi S MR .2011 .Preparation and evaluation of pellets using acacia and tragacanth by extrusion-spheronization. DARU J. Pharm. Sci., 19(6) : 417.
Anepu S,Duppala L,Pratyusha P .2015 .Development of hydrophobic carriers based tablets for sustained release of verapamil. J. Appl. Pharm. Sci., 12(5) : 125-134.
Ansari I,Bhusari S,Chaudhary A,Shrangare G .2020 .Formulation and evaluation of sustained release pellets of zidovudine by using extrusion and spheronization technique. Asian J. Pharm. Sci., 10(4) : 241-247.
Becker K,Salar-Behzadi S,Zimmer A .2015 .Solvent-free melting techniques for the preparation of lipid-based solid oral formulations. Pharm. Res., 32(5) : 1519-1545.
Beltrame A,Grangiè S,Guerra L S .2008 .Clinical experience with eperisone in the treatment of acute low back pain. Minerva Med, 99(4) : 347-352.
Bose K .1999 .The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial. Methods Find Exp. Clin. Pharmacol, 21(3) : 209-214.
Bresolin N,Zucca C .2009 .Efficacy and tolerability of eperisone and baclofen in spastic palsy: A double-blind randomized trial. Adv. Ther., 26(5) : 563.
Cabitza P and Randelli P .2008 .Efficacy and safety of eperisone in patients with low back pain: A double blind randomized study. Eur. Rev. Med, 12(4) : 229-235.
Rohera Chatlapalli R,BD Chatlapalli R .1998 .Physical characterization of HPMC and HEC and investigation of their use as pelletization aids. Int. J. Pharm., 161(2) : 179-193.
Cheboyina S,Chambliss WG,Wyandt CM .2004 .A novel freeze pelletization technique for preparing matrix pellets. Pharm. Technol. Int., 28(10) : 98-110.
Cheboyina S,Wyandt CM .2008 .Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique: I. Formulation and process variables affecting pellet characteristics. Int. J. Pharm., 359(1-2) : 158-166.
Chhipa P,Pethe AM,Upadhyay S,Tekade A .2009 .Formulation optimization of sustained release pellets of itopride hydrochloride using different polymers. J. Pharm. Res., 2(8) : 1404-1408.
Dassanayake LSK,Kodali DR,Ueno S,Sato K S .2009 .Physical properties of rice bran wax in bulk and organogels. J. Am. Oil Chem. Soc., 86(12) : 1163.
Dukic-Ott A,Remon JP,Foreman P,Vervaet C,Pharm C .2007 .Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/ spheronisation. , 67(3) : 715-724.
Enayatifard R,Saeedi M,Akbari J,Tabatabaee YH .2009 .Effect of hydroxypropyl methylcellulose and ethyl cellulose content on release profile and kinetics of diltiazem HCl from matrices. Trop. J. Pharm. Res., 8(5) : .
Feng H,Zhang L,Zhu C .2013 .Genipin crosslinked ethyl cellulose-chitosan complex microspheres for antituberculosis delivery. Colloids Surf. B. Biointerfaces, 103(2) : 530-537.
Gowda D,Ravi V,Shivakumar H,Hatna S H .2009 .Preparation, evaluation and bioavailability studies of indomethacin-bees wax microspheres. J. Mater. Sci. Mater, 20(7) : 1447-1456.
Gupta NV,Gowda D,Balamuralidhara V,Khan SM .2011 .Formulation and evaluation of olanzapine matrix pellets for controlled release. DARU J. Pharm. Sci., 19(4) : 249.
Hamdani J,Moes AJ,Amighi K AJ .2003 .Physical and thermal characterisation of Precirol® and Compritol® as lipophilic glycerides used for the preparation of controlled-release matrix pellets. Int. J. Pharm., 260(1) : 47-57.
Jain P,Jain S,Khan MA .2019 .Formulation and evaluation of extended release floating matrix tablet of eperisone hydrochloride by direct compression method. J. Drug Deliv. Ther., 9 : 86-92.
Jimenez A,Fabra M,Talens P,Chiralt A .2010 .Effect of lipid self-association on the microstructure and physical properties of hydroxypropylmethylcellulose edible films containing fatty acids. , 82(3) : 585-593.
Kranz H,Jurgens K,Pinier M,Siepmann J .2009 .Drug release from MCC-and carrageenan-based pellets: Experiment and theory. Eur. J. Pharm. Biopharm., 73(2) : 302-309.
Kunasekaran V,Rajarajan R,Kannan K,Manavalan R K .2012 .Dosage form design and evaluation of Eperisone hydrochloride matrix film coated extended release tablets. Int. J. Pharm. Pharm., 4(2) : 575-581.
Maboos M,Yousuf RI,Shoaib MH,Nasiri I,Hussain T,Ahmed HF,Iffat W .2018 .Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets. Lipids Health Dis., 17(1) : 136.
Mano T,Miyaoka T .1981 .Effects of muscle relaxant EMPP on afferent discharges of muscle spindle in man--an microneurographic analysis (author's transl). , 33(3) : 237-241.
Muschert S,Siepmann F,Leclercq B,Carlin B,Siepmann J .2009 .Prediction of drug release from ethylcellulose coated pellets. J. Control Release, 135(1) : 71-79.
Nasiri MI,Yousuf RI,Shoaib MH,Fayyaz M,Qazi F,Ahmed K F .2016 .Investigation on release of highly water soluble drug from matrix-coated pellets prepared by extrusion-spheronization technique. J. Coat. Technol., 13(2) : 333-344.
Nasiri MI,Yousuf RI,Shoaib MH,Zaheer K,Ali T,Ahmed K,Qazia F,Anwer S F .2019 .Formulation development and characterization of highly watersoluble drug-loaded extended-release pellets prepared by extrusion-spheronization technique. J. Coat. Technol., 16(5) : 1351-1365.
Nish S,Mathew G,Lincy J .2012 .Matrix tablets: An effective way for oral controlled release drug delivery. Iran. J. Pharm. Sci., 8(3) : 165-170.
Podczeck F,Rahman S,Newton J .1999 .Evaluation of a standardised procedure to assess the shape of pellets using image analysis. Int. J. Pharm., 192(2) : 123-138.
Pongjanyakul T,Medlicott NJ,Tucker IG .2004 .Melted glyceryl palmitostearate (GPS) pellets for protein delivery. Int. J. Pharm., 271(1-2) : 53-62.
Pozzi F,Furlani P,Gazzaniga A,Davis S,Wilding I .1994 .The time clock system: A new oral dosage form for fast and complete release of drug after a predetermined lag time. J. Control Release, 31(1) : 99-108.
Qazi F,Shoaib MH,Yousuf RI,Qazi TM,Mehmood ZA,Hasan SMF,Pak SMF .2013 .Formulation development and evaluation of diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M. , 26(4) : 653-663.
Rahman MA,Ahuja A,Baboota S,Bali V,Saigal N,Ali J .2009 .Recent advances in pelletization technique for oral drug delivery: A review. Curr. Drug Deliv., 6(1) : 122-129.
Remington ,Williams Lippincott .2000 .OCoLC)1019679546. The Science and Practice of Pharmacy, : .
Roblegg E,Jager E,Hodzic A,Koscher G,Mohr S,Zimmer A,Khinast J .2011 .Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion. Eur. J. Pharm. Biopharm., 79(3) : 635-645.
Guerra Sertini R,FAL Sertini R .2008 .Open experience with a new myrelaxent for low back pain. The J. App. Res., 8(2) : 226-232.
Singh R,Poddar S,Chivate A .2007 .Sintering of wax for controlling release from pellets. AAPS Pharm. Sci. Tech, 8(3) : E175-E183.
Sriamornsak P,Nunthanid J,Luangtana-Anan M,Weerapol Y,Puttipipatkhachorn S Y .2008 .Alginate-based pellets prepared by extrusion/ spheronization: Effect of the amount and type of sodium alginate and calcium salts. Eur. J. Pharm. Biopharm., 69(1) : 274-284.
Thommes M and Kleinebudde P .2006 .Use of κ- carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler. Eur. J. Pharm. Biopharm., 63(1) : 59-67.
Zeng WM .2004 .Oral controlled release formulation for highly water-soluble drugs: Drug-sodium alginatexanthan gum-zinc acetate matrix. Drug Dev, 30(5) : 491-495.